AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Ebola vaccine agreement expanded to include Marburg, Lassa vaccines.(Brief Article)

Vaccine Weekly

| September 18, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 SEP 18 - (NewsRx.com & NewsRx.net) -- Dutch antibody and vaccine company Crucell N.V. (CRXL) announced that it has expanded the Research Plan of its Cooperative Research and Development Agreement with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID).

The NIAID is part of the United States of America's primary biomedical research institute, the National Institutes of Health (NIH). In May 2002, Crucell entered into an agreement with the NIAID to develop an Ebola vaccine. The Research Plan of this agreement has now been expanded to include the development of vaccines to protect against Marburg and Lassa infections.

The vaccines against these diseases will be based on Crucell's vaccination platform, AdVac, and produced on Crucell's human cell line, PER.C6. The NIAID will create modified Ebola, Marburg, and Lassa genes, which will be used in making the vaccines.

Under the terms of the agreement, Crucell has the option for exclusive commercialization rights to the Ebola, Marburg, and Lassa vaccines. The vaccines are targeted towards people living in disease endemic areas in Africa, travelers, government officials, and military personnel. The ...

Related articles from newspapers, magazines, journals, and more
Another Outbreak of Hemorrhagic Fever in Africa: Marburg Virus.
Magazine article from: Infectious Disease Alert July 1, 1999 700+ words
...Outbreak of Hemorrhagic Fever in Africa: Marburg Virus abstract & commentary Synopsis...demonstrated to be due to the related Marburg virus. Source: WHO Weekly Epidemiologic...ncidod/dvrd/spb/ mnpages/dispages/marburg.htm. Beginning in april 1999, cases...
University Hospital Giessen and Marburg GmbH Select IntraOp Medical's Mobetron.
Press release article from: Business Wire November 18, 2008 700+ words
...eradication of cancer, today announced that it has received an order from University Hospital Giessen and Marburg GmbH (Marburg), located in Marburg, Germany. This will be the second Mobetron to be used in Germany to deliver intraoperative electron...
Risk factors for Marburg hemorrhagic fever, Democratic Republic of the...
Magazine article from: Emerging Infectious Diseases Bausch, Daniel G. Borchert, Matthias Grein, Thomas Roth, Cathy Swanepoel, Robert Libande, Modeste L. Talarmin, Antoine Bertherat, Eric Muyembe-Tamfum, Jean-Jacques Tugume, Ben Colebunders, Robert Konde, Kader M. Pirard, Patricia Olinda, Loku L. Rodier, Guenael R. Campbell, Patricia Tomori, Oyewale Ksiazek, Thomas G. Rollin, Pierre E. December 1, 2003 700+ words
...antibody surveys to assess risk factors for Marburg hemorrhagic fever in an area of confirmed Marburg virus transmission in the Democratic Republic...administered and serum samples tested for Marburg-specific antibodies by enzyme-linked...
Vaccine against Marburg virus performs successfully in test.
Newspaper article from: Frederick News-Post (Frederick, MD) April 27, 2006 700+ words
...FREDERICK -- In what could eliminate Marburg virus as a bioterrorism threat, scientists...which could one day be used in humans. Marburg caused outbreaks of hemorrhagic fever...and is a close cousin of Ebola virus. Marburg caused as much as a 90 percent fatality...
First Ebola/Marburg Vaccine Successfully Jumps Species.
Magazine article from: BIOWORLD Today November 3, 2009 700+ words
...into the human population. Ebola and Marburg virus outbreaks are rarer and more limited...Ebola, in about 24 hours. But Ebola and Marburg virus also are in the crosshairs of the...monkeys against infection with Ebola and Marburg virus - a model system that, while still...
Outbreak of Marburg virus hemorrhagic fever--Angola, October 1, 2004-March 29,...
Newspaper article from: Morbidity and Mortality Weekly Report April 1, 2005 700+ words
...Health Organization (WHO) confirmed Marburg virus (family Filoviridae, which includes...www.cdc.gov/travel/other/marburg_vhf_angola_2005.htm). This website...affected area are recommended at this time. Marburg virus disease presents as an acute febrile...
GenPhar's Vaccine Platform Yields Promising Results for Biowarfare Defense;...
Press release article from: Business Wire October 7, 2002 700+ words
...preliminary results from animal trials of its vaccine for Marburg virus. Marburg is a highly lethal hemorrhagic virus, similar to...Infectious Diseases (USAMRIID) which has identified Marburg virus as a potential biowarfare threat. GenPhar...
GOOD FOR MICE, GOOD FOR MACAQUES FIRST EBOLA/MARBURG VACCINE SUCCESSFULLY JUMPS...
Magazine article from: BIOWORLD Today Breindl, Anette June 10, 2005 700+ words
...into the human population. Ebola and Marburg virus outbreaks are rarer and more limited...Ebola, in about 24 hours. But Ebola and Marburg virus also are in the crosshairs of the...monkeys against infection with Ebola and Marburg virus - a model system that, while still...
For more facts and information, see all results

Source: HighBeam Research, Ebola vaccine agreement expanded to include Marburg, Lassa...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA